• No results found

Errata for

N/A
N/A
Protected

Academic year: 2021

Share "Errata for"

Copied!
1
0
0

Loading.... (view fulltext now)

Full text

(1)

Linköping University Medical Dissertations, No. 1286

Errata for

Epidemiological Studies of Multiple Sclerosis in Sweden

with Focus on the County of Värmland

Inger Boström February 17, 2012

1: Page 4: Paper IV …… Submitted to Multiple Sclerosis Journal (not Journal Multiple Sclerosis)

2: Page 21: the last aim….. to analyse the sex ratio in MS in the Swedish population…(not birth cohort)

3: Page 22: line 7 from bottom … crude MS mortality …. (not annual age- and gender-adjusted)

4: Page 28: the last line …. from 171.5% to 135.2% in MS, when compared the previous study (Landtblom et al. 2002) with the later study period, 1990-2010.

5: Page 31: line 3….. (Spearman´s rho = 0.664; p = 0.002; n = 21), (corrected figures)

6: Page 36: line 7 … (Spearman´s rho = 0.664; p = 0.002; n = 21) (corrected figures)

References

Related documents

The migration studies had shown increasing MS prevalence with increasing latitude [14]. Leibowitz et al. [31] noted that sanitation increases with latitude. Concerning

The specific viral childhood diseases measles, mumps, rubella and varicella do not influence the risk of MS, and may be dismissed as risk factors for MS. Infectious mononucleosis is a

Key words: Mycobacteria, Mycobacterium abscessus, colony morphology, mycobacterial lipids, epidemiology, cystic fibrosis, PFGE, human PBMC, cytokine, phagocytosis.

social/lifestyle activities were found in the sub-groups of people with MS with normal attention; normal manual dexterity; ability to walk without walking aid and support from

Another part of the case-control study showed that rheumatoid arthritis entailed an increased risk for multiple myeloma, a finding earlier suggested from register-based

The third used immunomodula- tory or immunosuppressive intervention (natalizumab, mitoxantrone or rituximab) and assessed MS patients pre- and 12-24 months post-treatment.

The third used immunomodulatory or immunosuppressive intervention (natalizumab, mitoxantrone or rituximab) and assessed MS patients pre- and 12-24 months post-treatment.

Keywords: Periodontal disease, dental caries, epidemiology, edentulousness, removable dentures, smoking, socio-behavioural, socioeconomic, tobacco, oral health related quality of